Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $740000.0.

  • Biomerica's Accounts Payables fell 1273.58% to $740000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $740000.0, marking a year-over-year decrease of 1273.58%. This contributed to the annual value of $672000.0 for FY2025, which is 4094.9% down from last year.
  • Latest data reveals that Biomerica reported Accounts Payables of $740000.0 as of Q4 2025, which was down 1273.58% from $681000.0 recorded in Q3 2025.
  • Biomerica's Accounts Payables' 5-year high stood at $2.6 million during Q1 2022, with a 5-year trough of $387228.0 in Q1 2023.
  • Its 5-year average for Accounts Payables is $897200.4, with a median of $748068.0 in 2021.
  • As far as peak fluctuations go, Biomerica's Accounts Payables skyrocketed by 24502.26% in 2022, and later plummeted by 8515.71% in 2023.
  • Biomerica's Accounts Payables (Quarter) stood at $1.6 million in 2021, then crashed by 57.61% to $670074.0 in 2022, then rose by 16.85% to $783000.0 in 2023, then rose by 8.3% to $848000.0 in 2024, then fell by 12.74% to $740000.0 in 2025.
  • Its Accounts Payables stands at $740000.0 for Q4 2025, versus $681000.0 for Q3 2025 and $672000.0 for Q2 2025.